Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 作为先后被评为”高新技术企业”、“广东省工程技术研究开发中心”、“广东省省级企业技术中心”的大型现代化制药企业，产品种类繁多，剂型齐全，拥有片剂、丸剂、小容量注射剂、合剂、颗粒剂等11个剂型101个国药准字号产品。“消炎利胆片”、“胆石通胶囊”、“石淋通片”和“脑力宝丸”等多个产品获国优和部优称号；“益心丸”、“珠贝定喘丸”、“穿心莲片”、“当归补血液”等多个产品获省优产品。“万年青”商标获“广东省著名商标”。 始终坚持以科技为先导，以质量谋发展，公司采取自主研发创新和与科研机构合作并重的方式，开发形成了胆道用药、心血管用药、儿科用药、妇科用药为核心的十大高品质药品生产系列。 “引领全球药业，健康每个家庭”作为企业毕生愿景的万年青，将高举自主创新的伟大旗帜，弘扬“济世养生，兴业报国”的企业精神，坚持“以德行仁、和谐共进”的宗旨，求真务实，奋力拼博，推进企业更稳妥、更扎实、更阳光、更健康地发展，为“振兴国药，造福人类”贡献自己智慧和力量。 公司主营业务为中成药的研发、生产和销售，产品应用范围涵盖胆道类、降糖类、清热解毒类、妇科类、补益类、儿科类、止咳平喘类、心脑血管类、感冒类、泌尿类、消化类、风湿类及伤科类13个用药领域。公司拥有片剂、硬胶囊剂、注射剂、丸剂、合剂、糖浆剂、颗粒剂、酒剂、酊剂、流浸膏剂和散剂11类剂型产品，主要产品包括消炎利胆片、胆石通胶囊、参芪降糖片、苦木注射液、妇炎平胶囊、归脾液、固精补肾丸、健儿清解液等。 公司拥有101个药品批准文号，其中10个产品为独家品种，4个产品为独家剂型，16个产品列入国家基药目录，39个产品列入国家医保目录，25个产品列入国家低价药目录。 2020年，因新冠肺炎疫情影响，公司增加了口罩的生产、销售业务，产品主要包括一次性使用医用口罩、医用外科口罩、KN95口罩等，适用人群包括成人和儿童。口罩业务进一步增加了公司的产品领域，增强了经营抗风险能力。
Main Business 中成药的研发、生产和销售。
Legal Representative 欧先涛
Top Executives
董事长：欧先涛
董事：欧泽庆,邱戊盛,陈秀燕
独立董事：李华青,杨学儒,郭剑
Top 5 Shareholder
Shareholder name Nature Holding Date
广东金欧健康科技有限公司限售股45.00%30/09/2024
合和投资控股（广州）合伙企业（有限合伙）流通A股11.25%30/09/2024
广东侨银房地产开发有限公司限售股7.50%30/09/2024
汕头市银康企业管理咨询合伙企业（有限合伙）限售股3.66%30/09/2024
广东中小企业股权投资基金有限公司流通A股2.40%30/09/2024
Company Secretary 陈秀燕
Solicitors 国浩律师（广州）事务所
Auditors 华兴会计师事务所（特殊普通合伙）
Tel No 0754-88119688
Fax No 0754-88119688
Website www.wnqzy.com.cn
Email zqb@wnqzy.com.cn
Company Address
Register: 广东省汕头市金园工业城潮阳路16片区08号
Office: 广东省汕头市金园工业城潮阳路16片区08号
Listing Date 07/12/2021
Shares Capital
Shares Capital: 160,000,000
Total A Share: 160,000,000
Listed A Share: 70,138,480
Non-tradable A Share: 89,861,520
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.210
DPS(RMB)* ¥ 0.100
NBV Per Share(RMB)* ¥ 4.851
Market Capitalization(RMB) 1.205B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.